These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

977 related items for PubMed ID: 9421921

  • 21. Inhibitory control in children with phenylketonuria.
    Christ SE, Steiner RD, Grange DK, Abrams RA, White DA.
    Dev Neuropsychol; 2006; 30(3):845-64. PubMed ID: 17083296
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Phenylalanine levels of 6-10 mg/dl may not be as benign as once thought.
    Diamond A.
    Acta Paediatr Suppl; 1994 Dec; 407():89-91. PubMed ID: 7766969
    [Abstract] [Full Text] [Related]

  • 24. Cognitive functions and the antioxidant system in phenylketonuric patients.
    Gassió R, Artuch R, Vilaseca MA, Fusté E, Colome R, Campistol J.
    Neuropsychology; 2008 Jul; 22(4):426-31. PubMed ID: 18590354
    [Abstract] [Full Text] [Related]

  • 25. Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control.
    de Sonneville LM, Huijbregts SC, van Spronsen FJ, Verkerk PH, Sergeant JA, Licht R.
    Mol Genet Metab; 2010 Jul; 99 Suppl 1():S10-7. PubMed ID: 20123462
    [Abstract] [Full Text] [Related]

  • 26. Cognitive findings and behavior in children and adolescents with phenylketonuria.
    Cappelletti S, Cotugno G, Goffredo BM, Nicolò R, Bernabei SM, Caviglia S, Di Ciommo V.
    J Dev Behav Pediatr; 2013 Jul; 34(6):392-8. PubMed ID: 23782895
    [Abstract] [Full Text] [Related]

  • 27. Neurocognitive functioning in adults with phenylketonuria: results of a long term study.
    Weglage J, Fromm J, van Teeffelen-Heithoff A, Möller HE, Koletzko B, Marquardt T, Rutsch F, Feldmann R.
    Mol Genet Metab; 2013 Jul; 110 Suppl():S44-8. PubMed ID: 24071437
    [Abstract] [Full Text] [Related]

  • 28. Tyrosine monitoring in children with early and continuously treated phenylketonuria: results of an international practice survey.
    Sharman R, Sullivan KA, Young RM, McGill JJ.
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S417-20. PubMed ID: 20882350
    [Abstract] [Full Text] [Related]

  • 29. Body protein in prepubertal children with phenylketonuria.
    Allen JR, Baur LA, Waters DL, Humphries IR, Allen BJ, Roberts DC, Gaskin KJ.
    Eur J Clin Nutr; 1996 Mar; 50(3):178-86. PubMed ID: 8654332
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Phenylketonuria diagnosed during the neonatal period and breast feeding].
    Cornejo V, Manríquez V, Colombo M, Mabe P, Jiménez M, De la Parra A, Valiente A, Raimann E.
    Rev Med Chil; 2003 Nov; 131(11):1280-7. PubMed ID: 14743689
    [Abstract] [Full Text] [Related]

  • 34. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C, Kiener C, Meier N, Schmid P, Rauh M, Rascher W, Knerr I.
    Ann Nutr Metab; 2008 Nov; 53(2):91-5. PubMed ID: 18946205
    [Abstract] [Full Text] [Related]

  • 35. Cerebral dopamine deficiency, plasma monoamine alterations and neurocognitive deficits in adults with phenylketonuria.
    Boot E, Hollak CEM, Huijbregts SCJ, Jahja R, van Vliet D, Nederveen AJ, Nieman DH, Bosch AM, Bour LJ, Bakermans AJ, Abeling NGGM, Bassett AS, van Amelsvoort TAMJ, van Spronsen FJ, Booij J.
    Psychol Med; 2017 Dec; 47(16):2854-2865. PubMed ID: 28552082
    [Abstract] [Full Text] [Related]

  • 36. Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function.
    DeRoche K, Welsh M.
    Dev Neuropsychol; 2008 Dec; 33(4):474-504. PubMed ID: 18568900
    [Abstract] [Full Text] [Related]

  • 37. Executive response monitoring and inhibitory control in children with phenylketonuria: effects of expectancy.
    Araujo GC, Christ SE, Grange DK, Steiner RD, Coleman C, Timmerman E, White DA.
    Dev Neuropsychol; 2013 Dec; 38(3):139-52. PubMed ID: 23573793
    [Abstract] [Full Text] [Related]

  • 38. Relation of prenatal phenylalanine exposure to infant and childhood cognitive outcomes: results from the International Maternal PKU Collaborative Study.
    Widaman KF, Azen C.
    Pediatrics; 2003 Dec; 112(6 Pt 2):1537-43. PubMed ID: 14654661
    [Abstract] [Full Text] [Related]

  • 39. The influence of blood phenylalanine levels on neurocognitive function in adult PKU patients.
    Bartus A, Palasti F, Juhasz E, Kiss E, Simonova E, Sumanszki C, Reismann P.
    Metab Brain Dis; 2018 Oct; 33(5):1609-1615. PubMed ID: 29948654
    [Abstract] [Full Text] [Related]

  • 40. Future role of large neutral amino acids in transport of phenylalanine into the brain.
    Matalon R, Surendran S, Matalon KM, Tyring S, Quast M, Jinga W, Ezell E, Szucs S.
    Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 49.